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Abstract
Background: Regional expression biases (REBs) are genetic intervals where gene expression is
coordinately changed. For example, if a region of the genome is amplified, often the majority of
genes that map within the amplified region show increased expression when compared to genes
located in cytogenetically normal regions. As such, REBs have the potential to act as surrogates for
cytogenetic data traditionally obtained using molecular technologies such as comparative genomic
hybridization. However as REBs are identified using transcriptional information, detection of REBs
may also identify local transcriptional abnormalities produced by both genetic and epigenetic
mechanisms.
Results: REBs were identified from a set of hepatocellular carcinoma (HCC) gene expression
profiles using a multiple span moving binomial test and compared to genetic abnormalities identified
using array-based comparative genomic hybridization (aCGH). In the majority of cases, REBs
overlapped genetic abnormalities as determined by aCGH. For example, both methods identified
narrow regions of frequent amplification on chromosome 1p and narrow regions of frequent
deletion on 17q. In a minority of cases, REBs were identified in regions not determined to be
abnormal via other cytogenetic technologies. Specifically, expression biases reflective of cell
proliferation were frequently identified on chromosome 6p21-23.
Conclusion:  Identification of REBs using a multiple span moving binomial test produced
reasonable approximations of underlying cytogenetic abnormalities. However, caution should be
used when attributing REBs identified on chromosome 6p to cytogenetic events in rapidly
proliferating cells.
Background
The parallel analysis of cytogenetic and transcriptional
profiling data has revealed that changes in DNA copy
number can have noticeable effects on gene expression.
Studies comparing wild-type and mutant strains of yeast
demonstrated that in regions of increased DNA copy
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number (i.e. genomic amplifications), the vast majority of
genes that mapped within the amplified region had
increased expression when compared to gene expression
in non-amplified regions [1]. In this context, the unidirec-
tional change in expression of a large number of adjacent
genes can be termed a regional expression bias (REB). The
dependence of gene expression on DNA copy number has
also been observed with human derived samples, for
example in a variety of aneuploid tumors and tumor
derived cell lines, and in tissues obtained from patients
with inherited trisomy disorders [2-13]. In these samples,
~40–70% of the genes that map to a cytogenetically
abnormal region show corresponding expression changes;
other genes within the region either do not change expres-
sion or, occasionally, change expression in the opposite
direction of the cytogenetic abnormality. Nevertheless, as
described in yeast, the majority of detectable regional
gene expression biases in these mammalian tissues also
coincide with chromosomal amplifications or deletions.
As such, it is feasible to infer cytogenetic abnormalities by
examination of high-density gene expression data. While
the majority of REBs correspond to cytogenetic abnormal-
ities, several groups have also identified a subset of
regional gene expression biases that do not coincide with
detectable DNA copy number changes [2,5,8,9,12,14].
While technical errors between DNA and expression-
based approaches may account from some of these differ-
ences, it is also possible that other epigenetic factors could
produce and regulate the appearance of REBs.
Partitioning gene expression data into subsets of adjacent
genes and applying a summary function to each subset is
a common method to identify REBs [1,5,11,15-19]. For
example, a chromosome can be broken into consecutive,
non-overlapping, 100 megabase (Mb) intervals and gene
expression values that map to each interval tested for an
expression biases using a variety of statistical/computa-
tional approaches. While partitioning approaches have
been effective in identifying REBs, these approaches may
be inherently limited due to the static nature of the parti-
tion span. Other, more dynamic, approaches to identify
REBs utilizing run and scan statistics have also been
reported [20]. However, the utility of these approaches for
genome-wide scanning of expression biases is not well
described.
Traditional data smoothing approaches ranging from sim-
ple moving averages to variable span local regression are
common and straightforward methods that can be used to
dampen variance and extract trends and patterns from
ordered data series. For example, array comparative
genomic hybridization (aCGH) data can be smoothed
using an exponentially smoothed moving average to more
easily identify abnormal chromosomal features [21].
While other approaches, such as hidden Markov models
can also be utilized to analyze ordered genomic data [22],
the complex nature of gene expression data may prevent
the direct application of a subset of these types of analysis
techniques. In this report, we outline an approach to iden-
tify REBs that summarizes the likelihood that each gene
expression value measured lies within an regional expres-
sion bias using a multiple span moving binomial test. We
use this approach to identify REBs in a set of hepatocellu-
lar carcinoma samples and compare the results to high
resolution cytogenetic data obtained by aCGH. We also
evaluated this approach using a set of clear cell renal cell
carcinoma (ccRCC) gene expression profiles. In the
majority of cases, dynamically determined REBs coincide
with regions of DNA copy number change as determined
by other molecular technologies. Interestingly, we identi-
fied a region on chromosome 6p where REBs are identi-
fied independent of apparent cytogenetic abnormalities.
We show that the REBs in this region are produced in the
most part by transcriptional responses to cellular
proliferation.
Results
Identification of regional expression biases
To identify REBs, a modified version of a moving average
is applied to two-color gene expression data obtained
from the comparison of tumor HCC tissue to adjacent
non-cancerous tissue (Figure 1a). Briefly, to calculate a
moving average given a series of gene expression values
ordered by genomic location and a window span that con-
sists of five data points, the first five gene expression val-
ues would be collected, the average of this set determined,
and the result stored as the first element of the moving
average. The next span would include the second through
the sixth gene expression values and the average of this
span stored as the second element of the moving average.
This process would continue until the end of the data
series and the results of the moving average could be
examined to identify trends. To identify REBs from
ordered gene expression data, rather then a use an averag-
ing function to evaluate each window span, an approxi-
mated binomial test is used to estimate of the probability,
in terms of a z-score, that a gene expression bias exists
within each span (see Materials and Methods). In this
case, a positive z-score would indicate a disproportionate
number of genes within the span show increased expres-
sion in the tumor profile when compared to the non-can-
cerous sample. Analogously, a negative z-score would
indicate a disproportionate number of genes within the
span show decreased expression in the tumor profile
when compared to the non-cancerous samples. In addi-
tion, rather then collect data from a single window span,
a data from a range of spans is collected and summarized
(Figure 1b). In this case, the smallest window span used is
25, while the largest window size used is n/3 = 93. A min-
imum span of 25 assures the estimated z-scores areBMC Genomics 2005, 6:67 http://www.biomedcentral.com/1471-2164/6/67
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reasonably accurate (see Material and Methods) and a
maximum span of n/3 prevents the generation of largely
redundant data. Typical of many types of data smoothers,
relatively small spans produce more variable REBs estima-
tions while larger spans produce broader, more diffuse,
REB estimations (Figure 1b). To estimate REB boundaries,
for each gene loci the mean z-score derived from the range
of window sizes is computed (Figure 1c). In addition, for
plotting, the final REBs is masked so that only significant
regions of bias are displayed. For simplicity, we term this
approach IR-CGMA, for Improved Resolution-Compara-
tive Genomic Microarray Analysis keeping in mind we
have essentially described the application of an
unweighted, multiple span, moving binomial test to iden-
tify REBs.
Validation of IR-CGMA
To test the effectiveness of this method, we compared
REBs identified by IR-CGMA to aCGH data derived from
the same set of samples (Figure 2a, b). Both IR-CGMA and
aCGH identified abnormalities that are commonly attrib-
uted to HCC such as +1q, -4q, -8p, +8q, -13q, -16q, -17p,
and +17q [6]. To summarize the similarities and differ-
ences between IR.CGMA and aCGH, the predicted frac-
tional allelic gain or loss was computed at each measured
locus (Figure 3a). In the majority of cases, IR.CGMA iden-
tified frequent regional expression biases that corre-
sponded to cytogenetic abnormalities as identified by
aCGH. For example, on chromosome 1 both approaches
identified a narrow region on the q-arm proximal to the
centromere (1q21-23) that is frequently amplified. In
addition, both approaches identified a region of frequent
deletion on the distal tip of chromosome 17 (17p13).
While in general REBs corresponded to features identified
by aCGH there are regions of discrepancy. The most strik-
ing discrepancy between REBs and aCGH/CGH is located
on chromosome 6p. Gain of chromosome 6p21-23 is not
a frequently reported cytogenetic event in HCC either in
this study or in other cytogenetic studies of HCC. How-
ever, chromosome 6p was frequently identified to be tran-
scriptionally abnormal via REB scanning. Additionally,
while gain of chromosome 17q frequently occurs in HCC,
there is some discrepancy between the fraction of samples
reported by IR-CGMA and aCGH.
Given these discrepancies, to provide additional valida-
tion for the use of a multiple span binomial test to iden-
tify regional expression biases, REBs were also identified
from a set of gene expression data derived from clear cell
renal cell carcinomas (ccRCC). Like HCC, ccRCC presents
with a consistent set of cytogenetic abnormalities includ-
ing loss of 3p and gain of 5p [23]. Frequent gain of chro-
mosome 12p has also been reported in some CGH studies
of ccRCC [24]. While in this study, we do not have corre-
sponding cytogenetic data for these specific samples to
perform direct comparisons, IR-CGMA did identify
abnormalities that overlap genetic abnormalities fre-
quently identified in ccRCC, including loss of 3p and gain
of 5p (Figure 4, 5). Interestingly, gain of chromosome 6p
is not a frequent cytogenetic abnormality associated with
Identification of regional expression biases Figure 1
Identification of regional expression biases. A multiple 
span moving binomial test was applied to gene expression 
data to identify regional expression biases. A. Plot of log2-
transformed tumor verses non-tumor expression ratios (m = 
468) that map to chromosome 6 of sample HK1 organized 
from the p-arm telomere (left) to the q-arm telomere (right). 
B. Heatmap of the set of estimations generated by applying 
an approximated binomial function (see Materials and Meth-
ods) to the gene expression data using window spans of i = 
[25,...,m/3]. Genomic regions that contains a disproportion-
ate number of relatively decreased expression values are 
shown in blue while genomic regions that show a dispropor-
tionate number of relatively increased expression values are 
shown in red. The color intensity indicates the significance of 
the expression bias. The highest intensity blue color indicates 
a z-score ≤  -4 while highest intensity red indicates a z-score 
≥  4 C. At each measured loci, an average z-score was com-
puted from the set of estimations from each window span 
shown in B and plotted. Significantly down-regulated regional 
expression bias estimations are highlighted in blue (z ≤  -1.96, 
p ≈  0.05) and up-regulated bias estimations highlighted in red 
(z ≥  1.96, p ≈  0.05).
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ccRCC, however, like the HCC samples, this region was
frequently identified as being abnormal via REB scanning.
While technical effects associated with either aCGH, tradi-
tional, CGH, or IR-CGMA may be responsible a subset of
these discrepancies, it is also possible that epigenetic tran-
scriptional regulation could contributes to the REBs.
Therefore, to determine if the transcriptional abnormali-
ties reflected certain types of epigenetic effects, we exam-
ined the gene expression data in more detail.
Examination of chromosome 6p and 17q REBs
To evaluate the nature of the REBs on chromosomes 6p
and 17q in HCC, misregulated genes within these regions
were identified and partitioned based on Gene Ontology
(Figure 6). Only two significantly enriched ontology's
were identified (p < 0.005) from the upregulated genes in
these regions: nucleic acid metabolism (GO:0006139)
and cell proliferation (GO:0009607) [25,26]. While a
small number of transcripts that had relatively increased
expression in the tumor samples were identified as nega-
tive regulators of cell proliferation (GO:0008283), overall
these results suggest that pronounced REBs on chromo-
some 6p and chromosome 17q reflect the active cell divi-
sion of the tumor cells compared to non-cancerous cells.
To test this hypothesis, up-regulated genes mapping to
these ontologies were removed from the HCC gene
expression dataset (154 of 8128 genes, 1.9%) and REBs
recomputed (Figure 3b). The REBs on chromosome 6p
were considerably diminished and the discrepancy on
chromosome 17q was partially diminished. In contrast,
REBs on chromosome 1q and 8q were not appreciably
changed after removing the cell proliferation associated
genes. Taken together, these results suggest that the tran-
scriptional effects of active cell proliferation participate in
the production of the REBs of 6p and 17q.
Discussion
In this paper, we describe the construction and applica-
tion of a straightforward data smoothing approach to
identify REBs from gene expression data. As evidence for
the validity of this approach, we demonstrate that REBs
overlap cytogenetic abnormalities as determined using
other cytogenetic profiling methods in the majority of
cases. Due to the dependence of gene expression on chro-
mosome dosage, identification of REBs can often assist in
the interpretation of gene expression data. For example,
detection of REBs can rapidly determine if a potential
cytogenetic abnormality associates with particular sample
classification, for example a more aggressive tumor sub-
type [27]. Perhaps more importantly, the prevalent over-
lap of transcriptional and cytogenetic abnormalities
support HCC tumorigenesis models that advocate that
recurrent cytogenetic aberrations, via their significant
influences on gene expression, play important roles in
HCC pathogenesis. In addition, the correlation between
Identification of REBs and DNA copy number abnormalities  from individual HCC samples Figure 2
Identification of REBs and DNA copy number abnor-
malities from individual HCC samples. 39 HCC sam-
ples were analyzed for REBs from gene expression data using 
IR-CGMA and for DNA copy number abnormalities from 
aCGH data using hidden Markov modelling. Corresponding 
chromosome ideograms for chromosomes 1, 4, 6, 8, 13, and 
17 are also shown to scale. The red bars in the ideogram 
highlight the centromere. A. IR-CGMA estimations were 
plotted as a heatmap to indicate significant expression biases 
as described in Figure 1. For consistent plotting, z-scores > 4 
and z-scores < -4 were set to 4 and -4 respectively. Scales 
ranging from 4 to -4 are shown adjacent to each graph. Data 
for all autosomal chromosomes for all samples was also gen-
erated [see Additional file 1]. B. aCGH predictions of 
genomic deletions (s ≤  -0.225, blue) and amplifications (s ≥  
0.225, red). The highest intensity blue color indicates a s ≤  -1 
while highest intensity red indicates s ≥  1. Scales ranging from 
1 to -1 are shown adjacent to each graph. Data for all auto-
somal chromosomes was also generated [see Additional file 
2].
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REBs and specific DNA copy number variation can assist
in identification of candidate genes that have important
function during tumorigenesis in a specific chromosomal
regions. For example, a narrow region on the q-arm of
chromosome 1 proximal to the centromere (1q21-23) is
predicted to be frequently amplified both by IR.CGMA
and aCGH, suggesting that this region may harbour can-
didate oncogenes. Inspection of genes that are highly
expressed in 1q21-23 included several signalling mole-
cules (MDUSP12, SHC1) and transcriptional factors
(MEF2D, ILF2, TCFL1). Particular interesting is ephrin-
A1, the ligand of Eph receptor tyrosine kinase. Ephrin-A1
has been implicated in angiogenesis and therefore may
contribute to HCC development [28]. Clearly, it is impor-
Summary of REBs and DNA copy number changes in HCC Figure 3
Summary of REBs and DNA copy number changes in HCC. A summary of the data generated as described in Figure 2. 
A. For each genetic loci on the autosomal chromosomes, the fraction of HCC samples that contained significant upwards 
expression biases were plotted as a positive fraction and the fraction of samples that contained significant downwards expres-
sion bias were plotted as a negative fraction. DNA copy number data determined by aCGH was plotted in a similar manner. B. 
Data was plotted as in A., with the exception that genes involved in cell proliferation and nucleic acid metabolism were 
removed, as described in the text, before REBs were identified.
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tant to evaluate the functions of these genes in HCC and
determine the extent in which their gene expression is reg-
ulated by DNA amplification.
We also demonstrate in this study that not all REBs corre-
sponded with detectable cytogenetic abnormalities, par-
ticularly in the region of chromosome 6p. Therefore, it is
appropriate to apply alternative molecular approaches
before attributing cytogenetic abnormalities to regional
expression biases located in this region. Classification of
the differentially expressed genes in this region into Gene
Ontologies suggests that the regional expression changes
reflect aspects of tumor cell proliferation as evidenced by
an enrichment of features classified in nucleic acid metab-
olism and cell proliferation GO categories. Another nota-
ble feature of chromosome 6p, particularly 6p21-23, is
that the gene density in this region is unusually high and
harbors gene clusters of several protein families [29]. The
unusually high gene density may also contribute to the
identification of this region as frequently abnormal by
REB scanning. It has been suggested that regions of high
gene density correlates with open chromatin fibers. This
open chromatin structure may facilitate transcriptional
activation if appropriate transcriptional signals are
present [30]. Other possible explanations of the REBs
include regional methylation or Histone deacetylation.
While the high variability of gene expression data may
prevent the direct application of several data modelling
approaches, this study suggests that application of tradi-
tional data smoothing methods are appropriate to infer
cytogenetic abnormalities from gene expression data and
are worth investigating further. One potential disadvan-
tage of smoothing approaches can be difficulty determin-
ing an appropriate window span that balances overall
smoothness with optimal feature identification. While
cross-validation using training and test data sets could
theoretically identify an optimal window span for
regional expression bias identification, we could not
derive a span that was appropriate for all chromosomal
regions across multiple data sets (data not shown). How-
ever, the increase in computer processing power allows
the utilization of more computational intensive multiple
span approaches to partially compensate for single span
effects.
Unlike traditional cytogenetic analysis approaches, the
resolution of this technique has a complex dependency
on gene density, gene coverage on the array platform used,
and tissue-dependent expression patterns. On average, the
genome contains about 10 genes per Mb and varies
between regions that have gene densities of ~6 genes per
Mb (chromosome 13) to regions that have gene densities
of ~26 genes per Mb (chromosome 19) [31]. As the
smoothing approach presented requires at least 25 gene
Identification of REBs from individual ccRCC samples Figure 4
Identification of REBs from individual ccRCC sam-
ples. 27 ccRCC samples were analyzed for REBs and plotted 
as described in Figure 2a with the exception that chromo-
somes 1, 2, 3, 5, 6, and 12 are shown. Chromosomes 1 and 2 
are shown as representative regions that do not frequent 
REBs. Data for all autosomal chromosomes was also gener-
ated [see Additional file 3].
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expression values to make a prediction, theoretically, the
resolution of a REB could average ~2.5 Mb across the
genome and range between ~1 to 4 Mb. However, for this
analysis the cDNA arrays used contained ~8500 features
could be confidently mapped to predicted genes. Of these
features ~6000 genes (70%) where expressed at measura-
ble levels in the liver tissue. Assuming ~30,000 human
genes, the resolution for this study would be about 5-fold
lower then the theoretically limits or average ~12.5 Mb
across the genome and range from ~5 Mb to ~20 Mb.
While not reported here, this approach is suitable for sin-
gle channel gene expression data provided appropriate
reference and test expression profiling data can be con-
verted to log-transformed expression ratios. We have also
successfully used this approach to infer cytogenetic abnor-
malities from other species, such as mice and rats.
Conclusion
In this report, we describe a method to identify regional
expression biases using a multiple span moving binomial
test. As evidence for the validity of this approach, we dem-
onstrate that this methods identifies REBs that associate
with cytogenetic abnormalities as determined by array
CGH and traditional CGH in both hepatocellular carci-
noma and clear cell renal cell carcinoma.
Methods
Pre-processing of gene expression data sets
Two-color gene expression profiles derived from 39 HCC
tumor samples and corresponding non-cancerous liver
samples [32], and 33 RCC and adjacent non-cancerous
kidney tissue samples [33], were obtained from the Stan-
ford Microarray Database [34]. In all cases, gene expres-
sion values were normalized using the within-print tip
group normalization method as implemented in the Bio-
Conductor packages for the R environment [35,36]. Prior
to normalization, R and G values were threshold such that
R or G values <150 were set to 150. In these data sets, the
cancerous and non-cancerous samples were compared to
a pooled cell-line reference. To allow direct comparison of
tumor to non-cancerous expression values, new gene
expression ratios (R) were generated from tumor tissue
ratio (T/U) and corresponding adjacent non-cancerous
tissue ratios (N/U) such that R = log2(T/U) - log2(N/U)
[2]. Sequence comparisons were used to map microarray
probe sequences to predicted Ensembl transcripts
(Ensembl version 19) [29]. Included in the Ensembl tran-
script annotations are chromosomal mapping locations at
base-pair resolution. If multiple probes mapped to the
same locus a mean gene expression value was utilized.
Pre-processing of array comparative genomic 
hybridization data sets
Two-color array CGH data for the HCC samples was gen-
erated essentially as described [37]. A manuscript
describing the details of the HCC copy number data and
initial analysis is in preparation. In all cases, copy number
values were transformed into copy number states using an
unsupervised hidden Markov model as implemented in
the BioConductor packages for the R environment
[22,36]. States in which the median copy number change
Summary of REBs in ccRCC Figure 5
Summary of REBs in ccRCC. 27 ccRCC samples were analyzed for REBs and plotted as in Figure 3a.
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was ≥  0.225 were defined as region of DNA gains and
states in which the median copy number change ≤  -0.225
were defined as regions of DNA loss [37].
Identification of regional expression biases (IR-CGMA 
method)
Gene expression values were separated into chromosome
subsets and ordered by gene mapping location. A sliding
window algorithm was applied to each ordered gene
expression subset such that within each window span a
binomial test was applied under the assumption that the
probability (p) of the appearance of a positive relative
gene expression value equals the probability (q) of the
appearance of a negative relative expression value, p = q =
0.5, and a z-score for the span is computed using the nor-
mal approximation to the binomial distribution. The z-
score can be converted to an approximate significance val-
ues based on the two-tailed z-statistic (za/2) critical values.
Data was generated using multiple window spans and an
average z-score at each gene location was computed. More
formally, given a set of ordered gene expression values gj
for genes j = 1, 2, ...m, let xij denote expression bias approx-
imations for genes j = 1, 2, ...m using window spans i = 25,
26, 27, ...m/3 where n denotes the number of window
spans examined. An empty matrix X[n#m] is populated
such that   for m-i+2 >j  ≥  i where t
denotes the number of non-zero and r the number of pos-
itive values within the span {gk, gk+1, ...gk+i-1}. To not dis-
card regions, xij  is tapered when j  <i  such that
 and analogously tapered when j ≥  m-i+2.
Final regional expression bias estimates (bj) are computed
such that  . Performing IR-CGMA on the 39
HCC gene expression profiles took approximately five
minutes on a 2.6 GHz Intel Pentium IV with 1 GB of RAM.
Identification of misregulated genes
Identification of misregulated genes from the HCC gene
expression profiles occurred in two-steps. First, genes were
filtered to ensure each gene was well measured across the
data set using an exact binomial test (p < 0.05). In this
case, data was required in 24 of 39 (64%) of samples.
Next, a one-sample t-test assuming unequal variance was
applied to determine if expression values were signifi-
cantly misregulated (p < 0.05).
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Functional classification of differentially expressed genes on  6p and 17q Figure 6
Functional classification of differentially expressed 
genes on 6p and 17q. Genes on chromosome 6p and chro-
mosome 17q that are differentially expressed in HCC com-
pared to adjacent non-cancerous tissue were identified as 
described in the Material and Methods. The t-statistic corre-
sponding to each misregulated gene (p < 0.05) was plotted 
with respect to gene location. For consistent plotting, t-sta-
tistics > 10 and t-statistics < -10 were set to 10 and -10 
respectively. Genes classified as nucleic acid metabolism, cell 
proliferation, and negative regulation of cell proliferation are 
highlighted orange, red, and cyan, respectively.
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